Applicant, as named in the Orange Book
Hospira Inc
Pfizer Inc · NYSE: PFE
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Products with listed protection
| Drug | Earliest generic entry |
|---|
None.
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products without listed protection (6)
| Drug | Earliest generic entry |
|---|---|
| Docetaxel NDA 022234 · 6 strengths docetaxel | open now no listed protection |
| Gemcitabine Hydrochloride NDA 200795 · 3 strengths gemcitabine hydrochloride | open now no listed protection |
| Hydromorphone Hydrochloride NDA 200403 · 5 strengths hydromorphone hydrochloride | open now no listed protection |
| Morphine Sulfate NDA 202515 · 5 strengths morphine sulfate | open now no listed protection |
| Nipent NDA 020122 pentostatin | open now no listed protection |
| Topotecan Hydrochloride NDA 200582 topotecan hydrochloride | open now no listed protection |